Seeing Is Believing
Currently out of the existing stock ratings of Jason Kolbert, 131 are a BUY (87.33%), 16 are a HOLD (10.67%), 3 are a SELL (2%).
Analyst Jason Kolbert, currently employed at DAWSON JAMES, carries an average stock price target met ratio of 53.33% that have a potential upside of 55.11% achieved within 400 days.
Jason Kolbert’s has documented 240 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CTSO, Cytosorbents Crp at 01-Oct-2024.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 2/10/2020. The price target of $12 was fulfilled within 74 days with a profit of $8.38 (231.49%) receiving and performance score of 31.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4 years 4 months 22 days ago
0/2 (0%)
$7.2 (167.00%)
Hold
4 years 10 months 9 days ago
0/1 (0%)
$1.7 (32.08%)
Which stock is Jason Kolbert is most bullish on?
Which stock is Jason Kolbert is most reserved on?
What Year was the first public recommendation made by Jason Kolbert?